EspaƱola, Cherlyn L.
HRN: 21-33-59 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
05/17/2022
CEFUROXIME 750MG (VIAL)
05/17/2022
05/24/2022
IV
1.5g Loading Dose Then 750mg
Q8h
Nephrolithiasis; Uti
Indication: Empiric Type of Infection: Urinary Tract Compliance to guidelines: Non-compliant To Guidelines